| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | 0.38 | 0.02 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.079 | 0.02 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.02 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.02 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.03 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.03 |